Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Endoscope Sees Backward

By HospiMedica staff writers
Posted on 14 May 2007
A new imaging device used during colonoscopy provides an additional view that can reveal polyps, cancers, and other lesions that might be missed during a standard colonoscopy procedure.

The Third Eye Retroscope auxiliary endoscopy system is passed through the instrument channel of a standard colonoscope until it extends beyond its tip. More...
As it emerges, the device automatically turns around 180o to aim back toward the tip of the colonoscope. Then, as the colonoscope is withdrawn, the Third Eye follows along to provide a continuous retrograde view of the colon. This retrograde view complements the forward view of the colonoscope and may reveal abnormalities that are hidden behind folds and flexures.

A laboratory bench study found that the device dramatically improved the ability of endoscopists to detect simulated polyps in anatomic models, and a pilot study demonstrated the feasibility of the device for use in humans. A larger clinical study to evaluate efficacy is currently in progress. The Third Eye Retroscope was developed by Avantis Medical Systems (Sunnyvale, CA, USA). The system has been approved by the U.S. Food and Drug Administration (FDA).

"Because the Third Eye works in conjunction with a standard colonoscope, it simply takes the best existing technology and makes it even better,” said David Watts, M.D., a co-founder of the company and member of the Avantis scientific advisory board. "That means facilities don't need to make major capital outlays to replace existing equipment, and endoscopists have to make only minor adjustments to the techniques that they've used successfully for years.”

Colonoscopy is widely regarded as the gold standard for detection of abnormalities in the colon. However, research has shown that a significant number of polyps and cancers may be missed during colonoscopy. In about 2/3 of cases where abnormalities are missed, it is because they lie behind flexures (tight turns) or behind folds in the colon wall that hides them from the forward-viewing colonoscope.


Related Links:
Avantis Medical Systems

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.